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Background: Limiting expansion of the ischemic core lesion by reinstating blood flow and protecting the penumbral
cells is a priority in acute stroke treatment. However, at present, methods are not available for effective drug delivery to
the ischemic penumbra. To address these issues this study compared the extravasation and subsequent interstitial
spread of a magnetic resonance contrast agent (MRCA) beyond the ischemic core into the surrounding brain in a rat
model of ischemia-reperfusion for bolus injection and step-down infusion (SDI) protocols.
Methods: Male Wistar rats underwent middle cerebral artery (MCA) occlusion for 3 h followed by reperfusion.
Perfusion-diffusion mismatched regions indicating the extent of spread were identified by measuring cerebral blood
flow (CBF) deficits by arterial spin-labeled magnetic resonance imaging and the extent of the ischemic core by
mapping the apparent diffusion coefficient (ADC) of water with diffusion-weighted imaging. Vascular injury was
assessed via MRCA, gadolinium-diethylenetriaminepentaacetic acid (Gd-DTPA) penetration, by Look-Locker T1-weighted
MR imaging after either a bolus injection (n = 8) or SDI (n = 6). Spatial and temporal expansion of the MRCA front
during a 25 min imaging period was measured from images obtained at 2.5 min intervals.
Results: The mean ADC lesion was 20 ± 7% of the hemispheric area whereas the CBF deficit area was 60 ± 16%,
with the difference between the areas suggesting the possible presence of a penumbra. The bolus injection led
to MRCA enhancement with an area that initially spread into the ischemic core and then diminished over time.
The SDI produced a gradual increase in the area of MRCA enhancement that slowly enlarged to occupy the core,
eventually expanded beyond it into the surrounding tissue and then plateaued. The integrated area from SDI
extravasation was significantly larger than that for the bolus (p = 0.03). The total number of pixels covered by the
SDI at its maximum was significantly larger than the pixels covered by bolus maximum (p = 0.05).
Conclusions: These results demonstrate that the SDI protocol resulted in a spread of the MRCA beyond the ischemic
core. Whether plasma-borne acute stroke therapeutics can be delivered to the ischemic penumbra in a similar way
needs to be investigated.
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Preserving the penumbra, the potentially salvageable area
of brain tissue adjacent to an infarct core, is a primary ob-
jective following cerebral ischemia [1-3]. If successful, it can
counter the expansion of the irreversibly damaged core and
conserve penumbral cells for subsequent restorative and re-
habilitative therapeutic interventions. Ways to achieve this
are to reperfuse the ischemic tissue as quickly as possible
and to deliver drugs that can enable the penumbral cells to
withstand less than optimal conditions until a favorable
milieu is re-established [4]. While approaches to initiate
reperfusion including thrombolysis and mechanical clot
retrieval are available, the delivery of therapeutics ne-
cessary for cell survival has proven difficult [5,6].
A major obstacle to brain drug delivery is the presence of
a highly selective blood–brain barrier (BBB) [7]. Attempts
have been made to overcome this obstacle by transiently
opening the BBB via infusion of hyperosmotic mannitol [8],
focused ultrasound [9,10] and ultrashort pulsed laser [11].
However, several brain pathologies including stroke, result
in BBB opening [12-14] and evidence exists that this
opening can be transient in acute stroke [15,16]. Post-
stroke BBB opening results in extravasation of plasma-
borne water and proteins into the brain [15,17] and their
uptake by damaged or apoptotic cells in the vicinity [18,19].
Thus, it seems reasonable to assume that stroke-induced
acute BBB opening, while being part of the pathology, may
also be a potential conduit for the passage of therapeutics
into the damaged brain. However, how to best use this
route to preserve the penumbra has received relatively little
attention.
Imaging modalities such as magnetic resonance imaging
(MRI) or computer-aided tomography are frequently
employed to measure tissue status in stroke and other
cerebral pathologies. Of these, dynamic contrast-enhanced
(DCE)-MRI provides the most data on brain vascular sta-
tus. In acute stroke, the presence and magnitude of BBB
opening needs to be evaluated as part of the patient screen-
ing process, since it can be a discriminating factor in decid-
ing the course of thrombolytic treatment [20-22]. As the
ischemic injury evolves, the BBB often becomes damaged
allowing extravasation of water and plasma-borne sub-
strates [23]. One potential method for assessing such
post-stroke vascular injury is to use MRI to track the
interaction of water molecules with a leaking magnetic
resonance contrast agent (MRCA) [24]. In a typical study,
an intravenous bolus injection of a Gd-based MRCA is
given and quantitative T1-weighted images are acquired to
visualize its enhancement. A bolus injection leads to a
rapid rise in blood MRCA levels followed by an exponen-
tial fall. This continuously falling blood level may not be
useful to study MRCA extravasation and its spread with
extracellular fluid flow. MRCA backflux may also take
place following a bolus injection if the BBB openings arerelatively large [25]. Thus, despite its widespread use, a
bolus injection may not be optimal to localize and quantify
BBB damage [26,27]. In contrast, a step-down infusion
(SDI) protocol can lead to near steady-state blood MRCA
levels and generate higher signal-to-noise ratios [28]. It
also results in superior visualization of BBB lesions and ac-
curate localization of even very small BBB openings in
acute stroke [29]. Therefore, we hypothesized that a SDI
of an MRCA will be better than a bolus input for measur-
ing the extent of vascular leakage in acute ischemia-
reperfusion -induced BBB damage. A rat model of transient
unilateral cerebral ischemia followed by reperfusion
was used to test the hypothesis.
Methods
Animals and MRI
Experimental protocols were approved by the Institutional
Animal Care and Use Committee. The MRCA, Gd-DTPA,
was prepared at a concentration of 400 mM using pub-
lished methods [30]. Male Wistar rats (Charles River,
Wilmington, MA, USA) weighing ~300 g were anesthe-
tized using 1.5% halothane in N2O:O2, 70:30. Following
published techniques [31], the right middle cerebral ar-
tery (MCA) was occluded using a 2 cm long, 4.0 nylon
monofilament with a heat-blunted tip. A femoral artery
and vein were cannulated with PE-50 tubing for monitoring
arterial pressure and blood gasses, and for MRCA adminis-
tration, respectively. The rat was placed on a feedback
controlled, water-heated rubber mat in an acrylic holder
equipped with a nose cone for inhalation anesthesia ad-
ministration during MRI.
All studies were performed using a 7-Tesla, 20-cm bore
superconducting Magnex magnet (Magnex Scientific Inc.,
Abingdon, UK) interfaced to a Bruker console (Bruker
Biospin MRI, Inc., Billerica, MA, USA) and equipped
with a 12-cm self-shielded gradient set capable of pro-
ducing 25 G/cm gradients with 100 μs rise times. Mea-
surements of CBF, T2, T1 and diffusion-weighted imaging
(DWI) were performed to localize the ischemic lesion fol-
lowing published methods [24,32-34]. At 3 h post-ictus,
the holder was pulled out and the occluding nylon suture
was withdrawn to initiate reperfusion and the rat returned
to the magnet for additional imaging. Post-reperfusion im-
ages, identical to those acquired during occlusion, were
obtained to assess the effects of reperfusion. At ~2.5 h
post-reperfusion, baseline T1-weighted images (T1WI) were
collected and then Gd-DTPA was intravenously adminis-
tered either as a bolus or SDI [28]. The bolus injection con-
sisted of 60 μl of the Gd-DTPA stock diluted to 120 μl with
normal saline given through the femoral vein over about
5 s. For the SDI, the infusate was prepared by diluting
240 μl of the Gd-DTPA stock solution to 4.0 ml with saline
and approximately 3.5 ml was infused over a period of
5 min using a syringe pump following published methods
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obtained every 2.5 minutes using a Look-Locker (LL)
sequence [TR/TE = 2000 ms/2.2 ms, 5 slices, 2 mm
thick, matrix 128 × 64, FOV= 32 mm] for approximately
25 minutes.
Histology
After MR imaging, the animals were removed from the
magnet and decapitated under deep anesthesia. The sev-
ered heads were instantly dropped into 2-methylbutane
cooled to −45°C with dry ice. The brains were thus rapidly
frozen in situ and carefully dissected from the heads in a
chest freezer without thawing and embedded in Shandon
M1 matrix (Thermo Electron Corporation, Pittsburgh, PA,
USA). Coronal 20 μm-thick frozen sections were taken at
400 μm intervals spanning the brain from frontal to striate
cortex. The sections were stained with cresyl violet (Nissl)
and differences in staining intensity used to delineate the
border between normal and ischemia-damaged tissue [34].
Image analysis
Following off-line segmentation to exclude extra-cranial
tissue, maps of ADC, CBF and subtraction LL-T1 images
were made from data acquired during MCA occlusion
and reperfusion [24,29,32-34]. A pulsed gradient spin-
echo imaging sequence with progressively incremented
diffusion-weighting (b-value) was used to measure ADC
[34]. Maps of ADC were produced from a straight line
least squares estimate of the slope from a plot of natural
log of normalized image intensity vs. gradient b-value
[34]. One standard deviation was subtracted from the
mean contralateral ADC value to segment the ipsilateral
ADC lesion and the number of pixels exhibiting low ADC
values was counted. CBF rates (ml/min/100 g) were mea-
sured from a single central slice of CBF map generated
from an arterial spin labeling sequence. The extent of T2
abnormality in the ipsilateral hemisphere was used to de-
marcate area of the CBF reduction and the number of
such pixels was recorded. The pixel numbers of the ipsilat-
eral and contralateral hemispheres were also measured
separately. The difference in pixel numbers between the
ipsi- and contralateral sides was considered to represent
stroke-induced brain swelling, was subtracted from the ip-
silateral value which was then used as the denominator to
calculate hemispheric fractions of pixels with ADC and
CBF lesions and contrast enhancement.
Following published methods [32], the MRCA-enhancing
brain regions were selected from the LL-T1 maps by thresh-
olding the pixel intensity of the post-contrast T1s to +2
standard deviations of the pre-MRCA image. The number
of enhancing pixels in each rat at each time point was
normalized to the largest area measured. The number
of maximal enhancing pixels from each input as well as
the area under the averaged curve for each input weremeasured and compared. All data were averaged for
mean ± standard deviation (SD) for the two groups and
significances inferred at p ≤ 0.05 using Student∞s t-tests.Results
Occlusion of the MCA reduced CBF to ~30% compared
to the corresponding contralateral values in the region
affected by occlusion. Reperfusion resulted in partial res-
toration of CBF (Figure 1). The extent of this rebound var-
ied, with the preoptic area showing about 40% and the
striatum about 50% of the corresponding contralateral
flow. The ADC lesion size did not change significantly dur-
ing the time from occlusion to reperfusion and was smaller
than the corresponding CBF deficit area (Figure 2). Re-
gional differences in BBB opening were also observed. Sub-
cortical regions, such as the preoptic area and striatum,
were affected more frequently (8 out of 12 rats) than neo-
cortical regions. In the superior sagittal sinus, used to
measure blood MRCA levels, the bolus injection resulted
in a maximum ΔR1 (R1 = 1/T1, longitudinal relaxation rate
and a measure of contrast agent concentration [24]) of
0.02 ms−1 in the first acquired image at 2.5 min corre-
sponding to the peak blood level during that period and
then decreased sharply over the next 2.5 min. The ΔR1
values continued to decline as the blood MRCA levels
gradually fell and nearly leveled off 15–25 min. The SDI re-
sulted in a similar initial increase (ΔR1 = 0.02) over the first
2.5 min and then stayed at nearly the same level during the
course of imaging. The relative areas under the curve
(AUC) for the two arterial input functions were 1.5 ± 0.05
and 2.8 ± 0.5 in the bolus and SDI groups, respectively.
Representative images showing temporal leakage en-
hancement from the bolus and SDI inputs are shown in
Figures 3 and 4, respectively. Initial enhancement after
bolus injection was larger than after SDI, in line with the
initial peak in blood levels immediately after injection
(Figure 3). Conversely, the enhancement after SDI ex-
panded comparatively slowly, but showed a steady and
sustained enlargement (Figure 4). Quantification of the
temporal expansion of contrast enhancement boundary
from post-contrast images showed that for bolus injec-
tion the area of enhancement reached a peak during the
first few scans after injection and then steadily decreased
(Figure 5A). With a SDI input, however, the area of en-
hancement increased slowly in the beginning, but con-
tinued to increase throughout the imaging period and
tending to plateau toward the end of the imaging dur-
ation (Figure 5A). The difference between the areas
under the curves from the two input functions was sig-
nificant (Figure 5B). The bolus at its maximum covered
about 130 ± 70 pixels and the SDI, about 280 ± 200 pixels.
The maximum hemispheric fraction area covered after
the bolus injection enhancement (around the 5th scan)
Figure 1 Images to exemplify the areas of ADC and CBF deficits (demarcated by white outlines) during occlusion (top row), and after
reperfusion (middle row). Images were acquired 1.5-2.5 h post-stroke and 0.5-3.0 h post re-perfusion. Note the expansion of ADC lesion by a
small extent and the partial restitution of CBF after reperfusion indicated by the appearance of relatively brighter pixels in the CBF deficit region.
The animals were sacrificed following the MRCA enhanced imaging series (performed between 2.5 h and 3.0 h post-reperfusion) at approximately
3 h post-reperfusion and tissue sections were taken for histopathological assessment. The bottom photomicrograph shows the Nissl stained brain
section from the same animal and demonstrates the stroke lesion (white outline) as seen on histopathology. It approximates the area of CBF
deficit still persisting after reperfusion. An increase in Nissl staining intensity is faintly visible from medial to lateral part of the lesion, with the
area of low intensity staining roughly matching the ADC lesion (regions marked by dotted lines).
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and the difference was significant (Figure 5C).
Discussion
These data support the hypothesis that following ischemia-
reperfusion-induced BBB opening, an SDI input of Gd-
DTPA aids in the expansion of extravasating MRCA frontFigure 2 Quantification of ADC and CBF lesion areas. The pixels
encompassing these lesions are expressed as a fraction of the ipsilateral
hemisphere corrected for swelling. ADC-1, during MCA occlusion;
ADC-2, after reperfusion; CBF-1, during MCA occlusion; CBF-2, after
reperfusion. Images were acquired 1.5-2.5 h post-stroke and 0.5-3.0 h
post re-perfusion.beyond the ischemic core. A comparison of pixel fractions
for ADC and SDI (20% and 30%, respectively) corroborates
this notion. The shape of the stepped input maintained a
near-steady state plasma MRCA level and will have facili-
tated the positive driving force from blood-to-brain. Vaso-
genic edema is one of the direct consequences of BBB
opening in acute stroke and results in influx of water into
the brain. The Gd-based MRCA tracks the water protons
and can accurately represent their position and movement.
Contrast enhanced MRI, therefore, is a powerful tool to
image and quantify these events.
One possible reason for the greater success of the SDI in-
put could be the higher total amount of MRCA infused. It
should be noted, however, that a similar quantity given as a
bolus could have led to adverse cardiac reactions due to
the very high osmolality (>1000 mOsm/kg) of the MRCA.
Therefore, an SDI may also be the best way for physiolo-
gically delivering larger quantities of MRCA to demarcate
small BBB openings [29] and, as seen by the present data,
for tracking the fluid front. Reported blood-to-brain influx
rates from bolus and SDI inputs were not statistically dif-
ferent, demonstrating that the SDI itself does not affect
BBB permeability characteristics [28]. However, it would
Figure 3 Temporally acquired 10 post-contrast Look-Locker (L-L) T1-weighted images (T1WI) obtained over about 25 min following a
bolus injection of Gd-DTPA. The images demonstrate a region of enhancement that increased in size and signal intensity over the first 5 scans
and then decreased over time. The color scale bar on top represents lowest to highest values in arbitrary units from left to right (black to white).
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delivered using an SDI input for providing a similar sus-
tained enlarging enhancement pattern.
Two major mechanisms of fluid flow in brain extracel-
lular space (ECS) are diffusion and bulk flow [35,36].
Diffusion by nature is expected to result in equivalent
flow in all directions away from the source. Such unhin-
dered flow is not possible in brain tissue that is character-
ized by a tortuous ECS with a normal volume fraction of
~20% [37-39] which may be further decreased in ischemia
due to cell swelling. However, the temporal increase in
contrast enhancing areas in the images suggests a still
patent ECS at this time point after reperfusion. Bulk
flow, since it occurs along paths of least resistance, isgenerally assumed to be along perivascular pathways [40].
Thus, a combination of diffusion and filtration in the ECS
are likely the main mechanisms of the observed enlarge-
ment of the contrast enhancement. But, their relative
contributions to the observed spread of extravasated Gd-
DTPA are not clear from the present data. It is pertinent,
however, that in cold-injury-induced vasogenic brain edema,
linear distances traveled for tracers such as sucrose,
fluorescein-labeled albumin and Evans blue-tagged al-
bumin were larger than their theoretically predicted diffu-
sion distances suggesting a sizeable contribution also by
bulk flow under comparable circumstances [41]. In this
context it is relevant to note that the Gd-DTPA used in
the present study is a relatively small molecule (molecular
Figure 4 Temporally acquired 10 post-contrast L-L T1WIs obtained over about 25 min following a step-down infusion of Gd-DTPA. The
images demonstrate a region of enhancement that increased in size and signal intensity over the first 4–5 scans before reaching a relatively steady
state. The color scale bar on top represents lowest to highest values in arbitrary units from left to right (black to white). Note the persistent white- and
red-tinged pixels suggestive of greater magnitude of leakage in the center of the enhancing region representing the probable source of leakage.
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in brain. As a result, it is likely to remain interstitial after
leakage and spread over a larger area in the ECS. This as-
sumed extravascular presence of Gd-DTPA is based on
several previous observations as follows. The normal intra-
vascular plasma distribution volume in brain is around 2%
and the volume of extracellular space, about 20% as noted
above. The Patlak plot which is employed by us to measure
vascular kinetics in this model takes into account the intra-
vascular levels while computing the brain distribution
of Gd-DTPA. Such estimates for Gd-DTPA in stroke
have routinely given values far exceeding the normalintravascular plasma distribution volume of 2% [23,24,32,34].
Moreover, vasodilation alone, even if present, cannot
fully account for such large distribution volumes and
that implies extravascular presence of the tracer.
Vasogenic edema in stroke is an important epiphe-
nomenon, but has undergone little evaluation [14]. It is
conventionally measured by post-mortem wet and dry
tissue weight differences [42]. However, brain regional
differences and directionality of edema fluid movement
are lost by such measurements. Thus, in vivo measure-
ments are essential to demonstrate any temporal fluctua-
tions in acute BBB opening [43]. Apart from accurate
Figure 5 Quantification of differences in spatial and temporal expansion of enhancing areas with bolus and SDI inputs. (A) Normalized
area measurements (mean ± standard deviation) are plotted as a function of time for the bolus (n = 8) and step-down infusion (n = 6) protocols.
The first scan showed few enhancing pixels and is not plotted. Both inputs showed similarly increasing areas for the first 4 scans plotted. The
enhancing area for the bolus input, however, began to decrease after the first 5 scans and continued to decrease for the remainder of the
study (scans 6–10). Note that the mean last point has dropped down to nearly the same level as the first point shown (i.e., for the 2nd scan).
In comparison, the area of enhancement for the step-down protocol increased for the first 4–5 scans before reaching a relatively steady state
(scans 6–10). (B) Plot showing the areas under the curve (AUC) for the two input functions which differed significantly for the bolus versus
step-down injections on scans 8 and 9. The difference between the two mean values was significant (*p = 0.03). The values are scaled along
the left Y-axis. (C) Plot showing the maximum enhancing pixels from the two inputs as corrected fractions of ipsilateral hemisphere. The SDI
enhanced pixels covered about 30% whereas those from bolus covered about 12% of the total, the difference being statistically significant
(*p = 0.05). These values are scaled along the right Y-axis; error bars represent standard error of the mean.
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implications for this phenomenon such as the possibility
of utilizing the edema fluid diffusion and convection to de-
liver therapeutics via BBB openings [44]. Thus, it is rele-
vant that entry and uptake of blood-borne substrates into
brain tissue after ischemia-reperfusion injury have been
reported [15,18,19]. Also, the reported biphasic nature of
such openings [16,43] may provide a direct, but transient,
access to damaged brain under acute stroke.
Nevertheless, ischemia-induced changes in cerebral cyto-
architecture may impose further restrictions on effective
brain drug delivery. It is known that diffusion of molecules
after direct intracerebral injection is restricted [35,38].
Other brain drug delivery techniques have also met with
limited success [7,45]. As noted above, brain has a tightly
packed cell density, so most substances exhibit very low
diffusion coefficients within the brain parenchyma due to
either the tortuous ECS or molecular size [35]. In some
disease conditions, including stroke, the ECS may be fur-
ther constricted due to cell swelling. Therefore, it is not
enough to just get drugs beyond the BBB, but also vital
for them to traverse relatively long distances in effective
concentrations. Accordingly, a timely combination of both
BBB opening and an optimal drug administration schedule
that augments the drug’s brain entry and its subsequent
dispersion in brain seems warranted.
Previous data have shown that acute BBB opening in
this model of stroke is size-selective and allows the ex-
travasation of molecules up to several thousand Daltons in
weight [19]. Of these, the smaller tracers are more likely
to navigate longer distances than larger tracers [31]. Diffu-
sion of a drug molecule may similarly be hindered owing
to its size. Drug spread may also be restricted by neuronaland glial receptors and transporters that can result in cel-
lular uptake after leakage and limit its passage. However,
such an uptake that restricts the spread, but results in cel-
lular protection would still be a positive outcome. A con-
stant plasma drug level in such a scenario via an SDI input
is likely to facilitate greater penetration into brain, if such
drug delivery were to be attempted [44], and this study
provides the proof of this concept.
Conclusions
The window of opportunity to access the brain for sev-
eral neuroprotective molecules is reported to be within
24 h after stroke onset [46]. It is conceivable that this
phenomenon could be partly due to transient BBB open-
ing. In addition, a sequential “rescue first, rehabilitate next”
approach is reported to be beneficial to the ischemic brain
[47]. Thus, taking advantage of acute BBB opening to de-
liver neuroprotective drugs could be important in such
temporal therapy sequencing to treat stroke.
In this regard, we have shown that a step down infu-
sion protocol provides greater penetration and warrants
further investigations as a potential drug delivery tactic
using BBB opening for acute stroke treatment.
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